NASH limits anti-tumour surveillance in immunotherapy-treated HCC
NASH limits anti-tumour surveillance in immunotherapy-treated HCC is a paper indexed in ScholarIQ from OpenAlex.
How many citations does NASH limits anti-tumour surveillance in immunotherapy-treated HCC have?
NASH limits anti-tumour surveillance in immunotherapy-treated HCC has 1,271 citations in the OpenAlex counts ScholarIQ stores.
When was NASH limits anti-tumour surveillance in immunotherapy-treated HCC published?
NASH limits anti-tumour surveillance in immunotherapy-treated HCC has 2021 year in the ScholarIQ index.
What is the open-access status of NASH limits anti-tumour surveillance in immunotherapy-treated HCC?
NASH limits anti-tumour surveillance in immunotherapy-treated HCC has hybrid oa status in the ScholarIQ index.
What is the DOI of NASH limits anti-tumour surveillance in immunotherapy-treated HCC?
The DOI for NASH limits anti-tumour surveillance in immunotherapy-treated HCC is on the source record.
What is the PMID of NASH limits anti-tumour surveillance in immunotherapy-treated HCC?
The PMID for NASH limits anti-tumour surveillance in immunotherapy-treated HCC is on the source record.
What is the OpenAlex record for NASH limits anti-tumour surveillance in immunotherapy-treated HCC?
The OpenAlex for NASH limits anti-tumour surveillance in immunotherapy-treated HCC is on the source record.